Rheumatology (Oxford, England)
The risk of cardiovascular events following treatment for psoriatic arthritis with a biological agent.
Chung-Yuan Hsu, Shang-Hong Lin, Yu-Jih Su, Ming-Lung Tsai, Yuan Lin, Ning-I Yang, Tien-Ming Chan, Tien-Hsing Chen
Published: 202510.1093/rheumatology/keaf487
Abstract
OBJECTIVES: Psoriatic arthritis (PsA) increases cardiovascular disease risk. Emerging evidence suggests biologic Disease-Modifying Antirheumatic Drugs (DMARDs) may offer protective effects, though their advantage over conventional therapy remains und…
Preview only. Read the full abstract at the source